Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma

Pharmacogenetics

Volumn 11, Issue 6, 2001, Pages 521-535

  Gallou, C ^a   Longuemaux, S ^a   Delomenie C ^a   Mejean A ^a   Martin, N ^a   Martinet, S ^a   Palais, G ^a   Bouvier, R ^a   Droz, D ^a   Krishnamoorthy, R ^a   Junien, C ^a   Beroud C ^a   Dupret, J M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

GSTT1; Renal cell carcinoma; Transversion; VHL

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; GLUTATHIONE TRANSFERASE; ISOENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ACETYLTRANSFERASES; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LIGASES; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN; XENOBIOTICS;

EID: 17944377725     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200108000-00007     Document Type: Article

References (39)

1. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue
2. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas
3. Software and database for the analysis of mutations in the VHL gene
4. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma
5. VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation
6. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer
7. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1)
8. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene
9. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
10. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles
11. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
12. Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases
13. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population
14. Prognostic significance of morphological parameters in renal cell carcinoma
15. Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC
16. Mutations of the VHL tumour suppressor gene in renal carcinoma
17. Renal cell carcinoma
18. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
19. Prognostic significance of the 1997 TNM classification of renal cell carcinoma
20. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
21. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer
22. Mutation and cancer: Statistical study of retinoblastoma
23. Identification of the von Hippel-Lindau disease tumor suppressor gene
24. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas
25. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes
26. Epidemiologic aspects of renal cell cancer
27. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues
28. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTPI: Relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients
29. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
30. Studying interactions of four proteins in the yeast two-hybrid system: Structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKPl/cullin/F-box protein
31. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors
32. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer
33. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
34. Variation in induced CYP1A1 levels: Relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms
35. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: A case-control study
36. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics
37. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindan (VHL) tumor suppressor gene product
38. A second-generation linkage map of the human genome